Ann: OrthoATI Tendon Clinical Study Success, page-123

First 123 Last

Share
Profile

Follow
Mangoman605

1,650 Posts.

177

09/12/21

15:43

Post #: 58192660
Share

Originally posted by Hotdog11: ↑

KainCarver, we all feel the pain,

As stated before I’ve owned since 2014/2015 we have had 3 CR to raise funds to move the company through the next phases towards their goals

These institutional investors have had to cut losses soon after buying in, because of a share price heading south. I personally subscribe to a managed fund who have recommended Orthocell three times, three time they have lost money for there subscribers.

Mud sticks when you are losing money for your clients or subscibers. Let’s be honest if I was in control of a billion dollars of peoples superannuation, Orthocell wouldn’t even be on the radar.

This is the reason why retail hold such a big percentage of this company, over 76%. Now it’s only going to take one strike of a pen about a partnership to open this company up to a new type of investor, welcome to the international investor, where they are more than happy to take your cheap shares off you, just look at the games getting played with the likes of I.M.U

I have bought up big in this company with the intention of making millions, we are a lot closer than you might think

Expand

Well said HD. The fact that instos keep losing money
on OCC has a big bearing on the present share
price. Always the bridesmaid, never the bride.

OCC Price at posting: 57.5¢ Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The iron ore comeback: Can it last?

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ZNC

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

HAS

Hastings progressing Yangibana to production with lower costs

There are more pages in this discussion • 119 more messages in this thread...

First 123 Last

Add OCC (ASX) to my watchlist

(20min delay)
Last 42.5¢		Change 0.000(0.00%)		Mkt cap ! $89.07M

Open	High	Low	Value	Volume
42.0¢	42.5¢	41.5¢	$36.51K	87.26K

Buyers (Bids)

No.	Vol.	Price($)
1	1202	42.0¢

Sellers (Offers)

Price($)	Vol.	No.
42.5¢	48	1

View Market Depth

No.	Vol.	Price($)
1	1202	0.420
3	23256	0.415
5	26153	0.410
2	26293	0.405
7	82300	0.400

Price($)	Vol.	No.
0.425	48	1
0.430	26556	3
0.435	25000	1
0.440	36400	2
0.445	99431	2

Last trade - 14.37pm 30/09/2024 (20 minute delay)

OCC (ASX) Chart

Ann: OrthoATI Tendon Clinical Study Success, page-123

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The iron ore comeback: Can it last?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

Hastings progressing Yangibana to production with lower costs

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: OrthoATI Tendon Clinical Study Success, page-123

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The iron ore comeback: Can it last?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

Hastings progressing Yangibana to production with lower costs

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News